Crescent Park Management’s Cellebrite DI Ltd. Warrants CLBTW Stock Holding History

Crescent Park Management’s Portfolio CLBTW Stock Details CLBTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-32,500	Closed	-$93.9K	–	36
2024 Q2	$93.9K	Hold	32,500	–	–	0.04%	28
2024 Q1	$69.9K	Sell	32,500 -526,535	-94%	-$1.04M	0.03%	29
2023 Q4	$878K	Sell	559,035 -26,211	-4%	-$30.8K	0.19%	27
2023 Q3	$761K	Buy	585,246 +35,814	+7%	+$45.5K	0.18%	27
2023 Q2	$681K	Buy	549,432 +17,545	+3%	+$15.6K	0.2%	27
2023 Q1	$457K	Buy	531,887 +27,666	+5%	+$23.4K	0.15%	24
2022 Q4	$312K	Sell	504,221 -130,707	-21%	-$87.6K	0.1%	22
2022 Q3	$413K	Buy	634,928 +54,575	+9%	+$44.2K	0.1%	31
2022 Q2	$449K	Buy	580,353 +16,454	+3%	+$15K	0.1%	35
2022 Q1	$716K	Sell	563,899 -195,170	-26%	-$246K	0.12%	37
2021 Q4	$1.34M	Buy	759,069 +264,877	+54%	+$587K	0.22%	28
2021 Q3	$1.06M	Buy	+494,192	New	+$1.14M	0.16%	38

Crescent Park Management's CLBTW Position: Q3 2024 in Review

Crescent Park Management sold out of Cellebrite DI Ltd. Warrants (CLBTW) in Q3 2024, closing a stake of 32,500 shares — an estimated $93.9K sold.

Crescent Park Management first reported a position in CLBTW in Q3 2021 and held it in 12 quarters. The position peaked at $1.34M in Q4 2021. 0 funds tracked by Wall St. Rank hold CLBTW as of Q3 2024.

Crescent Park Management reported no remaining Cellebrite DI Ltd. Warrants position as of Q3 2024 after selling out during the quarter.
Crescent Park Management sold 32,500 Cellebrite DI Ltd. Warrants shares in Q3 2024, an estimated $93.9K.
Crescent Park Management first reported a position in Cellebrite DI Ltd. Warrants in Q3 2021 and held it in 12 quarters.
Crescent Park Management's Cellebrite DI Ltd. Warrants position peaked at $1.34M in Q4 2021.
0 funds tracked by Wall St. Rank held Cellebrite DI Ltd. Warrants as of Q3 2024.

Based on Crescent Park Management's 13F filing for Q3 2024, filed 13 Nov 2024.